• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性的存在会增加哮喘复发的风险。

Presence of atopy increases the risk of asthma relapse.

机构信息

Department of Paediatrics and Child Health, Centenary Hospital for Women and Children, Canberra, Australian Capital Territory, Australia.

Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

出版信息

Arch Dis Child. 2018 Apr;103(4):346-351. doi: 10.1136/archdischild-2017-312982. Epub 2017 Oct 11.

DOI:10.1136/archdischild-2017-312982
PMID:29021189
Abstract

OBJECTIVES

To describe the point prevalence of respiratory viruses/atypical bacteria using PCR and evaluate the impact of respiratory viruses/atypical bacteria and atopy on acute severity and clinical recovery in children with hospitalised and non-hospitalised asthma exacerbations.

DESIGN

This was a prospective study performed during 2009-2011.

SETTING

The study was performed in the emergency departments of two hospitals.

PATIENTS

244 children aged 2-16 years presenting with acute asthma to the emergency departments were recruited. A nasopharyngeal aspirate and allergen skin prick test were performed.

MAIN OUTCOME MEASURES

The outcomes were divided into (1) acute severity outcomes (Australian National Asthma Council assessment, hospitalisation, Functional Severity Scale, Acute Asthma Score, asthma quality of life questionnaires for parents (PACQLQ) on presentation, asthma diary scores (ADS) on presentation and length of hospitalisation) and (2) recovery outcomes (PACQLQ for 21 days, ADS for 14 days and representation for asthma for 21 days).

RESULTS

PCR for viruses/atypical bacteria was positive in 81.7% of children (75.1% human rhinovirus, codetection in 14.2%). and were rarely detected. The presence of micro-organisms had little impact on acute asthma or recovery outcomes. Children with atopy were significantly more likely to relapse and represent for medical care by day 14 (OR 1.11, 95% CI 1.00 to 1.23).

CONCLUSIONS

The presence of any viruses is associated with asthma exacerbations but does not appear to influence asthma recovery. In contrast, atopy is associated with asthma relapse. and are rare triggers of acute asthma in young children.

摘要

目的

使用 PCR 方法描述呼吸道病毒/非典型细菌的时点流行率,并评估呼吸道病毒/非典型细菌和特应性对住院和非住院哮喘加重患儿急性严重程度和临床转归的影响。

设计

这是一项在 2009-2011 年进行的前瞻性研究。

地点

研究在两家医院的急诊科进行。

患者

招募了 244 名 2-16 岁因急性哮喘就诊于急诊科的儿童。进行鼻咽抽吸物和过敏原皮肤点刺试验。

主要观察指标

结果分为(1)急性严重程度结局(澳大利亚国家哮喘理事会评估、住院、功能严重程度量表、急性哮喘评分、就诊时父母哮喘生活质量问卷(PACQLQ)、就诊时哮喘日记评分(ADS)和住院时间)和(2)恢复结局(21 天 PACQLQ、14 天 ADS 和 21 天哮喘表现)。

结果

病毒/非典型细菌的 PCR 检测阳性率为 81.7%(75.1%为人鼻病毒,14.2%为合并感染),很少检测到 和 。微生物的存在对急性哮喘或恢复结局的影响很小。特应性患儿在第 14 天复发和再次接受医疗的可能性明显更高(OR 1.11,95%CI 1.00 至 1.23)。

结论

任何病毒的存在均与哮喘加重相关,但似乎不会影响哮喘恢复。相比之下,特应性与哮喘复发相关。 和 是幼儿急性哮喘的罕见触发因素。

相似文献

1
Presence of atopy increases the risk of asthma relapse.特应性的存在会增加哮喘复发的风险。
Arch Dis Child. 2018 Apr;103(4):346-351. doi: 10.1136/archdischild-2017-312982. Epub 2017 Oct 11.
2
The impact of viral respiratory infection on the severity and recovery from an asthma exacerbation.病毒性呼吸道感染对哮喘急性加重的严重程度及恢复的影响。
Pediatr Infect Dis J. 2009 Apr;28(4):290-4. doi: 10.1097/INF.0b013e31819067b1.
3
Role of viruses and atypical bacteria in asthma exacerbations among children in Oporto (Portugal).病毒和非典型细菌在葡萄牙波尔图儿童哮喘急性加重中的作用。
Allergol Immunopathol (Madr). 2007 Jan-Feb;35(1):4-9. doi: 10.1157/13099088.
4
Viruses and atypical bacteria associated with asthma exacerbations in hospitalized children.与住院患儿哮喘加重相关的病毒和非典型细菌。
Pediatr Pulmonol. 2010 Jun;45(6):619-25. doi: 10.1002/ppul.21236.
5
Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children.儿童哮喘加重期病毒、肺炎衣原体及肺炎支原体感染的检测
J Clin Virol. 1999 Aug;13(3):131-9. doi: 10.1016/s1386-6532(99)00030-x.
6
Evaluation of the association between atypical bacteria infections and respiratory tract diseases with emphasis on bronchial asthma exacerbations in children.评估非典型细菌感染与呼吸道疾病之间的关联,重点关注儿童支气管哮喘急性发作。
Ann Univ Mariae Curie Sklodowska Med. 2004;59(1):105-11.
7
Application of three uniplex polymerase chain reaction assays for the detection of atypical bacteria in asthmatic patients in Kuwait.三种单重聚合酶链反应检测试剂盒在科威特哮喘患者中检测非典型细菌的应用。
J Infect Public Health. 2013 Apr;6(2):134-41. doi: 10.1016/j.jiph.2012.12.002. Epub 2013 Jan 28.
8
Comparison of Mycoplasma pneumoniae Infections in asthmatic children versus asthmatic adults.哮喘儿童与哮喘成人中肺炎支原体感染的比较。
Pediatr Infect Dis J. 2014 Mar;33(3):e71-5. doi: 10.1097/INF.0000000000000063.
9
[Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children].[病毒感染、肺炎衣原体及肺炎支原体感染在婴幼儿哮喘中的作用。对118名儿童的流行病学研究]
Arch Pediatr. 2002 Aug;9 Suppl 3:365s-371s. doi: 10.1016/s0929-693x(02)00145-8.
10
Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control.肺炎衣原体、肺炎支原体感染与哮喘控制。
Allergy Asthma Proc. 2011 Mar-Apr;32(2):9-17. doi: 10.2500/aap.2011.32.3431.

引用本文的文献

1
Recurrent Infections in Allergic Pediatric Patients: An Immune System Problem? A Narrative Review.过敏性儿科患者的反复感染:是免疫系统问题吗?一篇叙述性综述。
Children (Basel). 2025 Jun 17;12(6):788. doi: 10.3390/children12060788.
2
Bird's eye overview of asthma in children.儿童哮喘概述。
Indian J Med Res. 2021 Jul;154(1):8-11. doi: 10.4103/ijmr.IJMR_931_21.
3
from Down Under: The Curious Cases of Chlamydial Infections in Australia.来自澳大利亚:澳大利亚衣原体感染的奇闻病例
Microorganisms. 2019 Nov 22;7(12):602. doi: 10.3390/microorganisms7120602.
4
Sensitization to inhaled allergens in asthmatic children in southern Jordan: a cross-sectional study.约旦南部哮喘儿童对吸入性过敏原的致敏情况:一项横断面研究。
Multidiscip Respir Med. 2019 Nov 8;14:37. doi: 10.1186/s40248-019-0199-y. eCollection 2019.